EAU 2012 Report – Proactive Discussion about BPH
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
26 Feb 2012 – EAU Paris, France – What have been some of the EAU highlights to date? And what are some Key messages to share with Irish… read more.
Conclusions of the ICD for Life Summit held in Belgrade, Serbia “Implantable devices can save lives and decrease mortality, they are not a luxury”
by Edel O’Connell reporting on the presentation by Professor Eoin O’Brien.
by Edel O’Connell reporting on the presentation by Dr. Stephen Horgan.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
The Brussels Declaration, published in the European Respiratory Journal in 2008 recognises the high prevalence of patients with poorly controlled asthma and calls for changes in asthma management… read more.
The combination also appears to be cost effective. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with… read more.
by Bruce Sylvester – Revamped ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (STEMI) include issues of diagnosis and treatment before,… read more.
by Bruce Sylvester – Revamped ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (STEMI) include issues of diagnosis and treatment before,… read more.
In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).
by Zara Qadir – Every year, the EAHP holds a best poster competition to encourage hospital pharmacists from all over Europe and beyond, to share best practices and… read more.